The estimated Net Worth of Krista Fogarty is at least $49 mil dollars as of 17 May 2022. Ms Fogarty owns over 12,500 units of Lipocine Inc stock worth over $49,000 and over the last 3 years she sold LPCN stock worth over $0.
Sign up
Ms Fogarty LPCN stock SEC Form 4 insiders trading
Ms has made over 1 trades of the Lipocine Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she bought 12,500 units of LPCN stock worth $10,750 on 17 May 2022.
The largest trade she's ever made was buying 12,500 units of Lipocine Inc stock on 17 May 2022 worth over $10,750. On average, Ms trades about 4,167 units every 0 days since 2022. As of 17 May 2022 she still owns at least 12,500 units of Lipocine Inc stock.
You can see the complete history of Ms Fogarty stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Krista Fogarty biography
Krista Fogarty is the Principal Accounting Officer & Corp. Controller at Lipocine Inc.
How old is Ms Fogarty?
Ms Fogarty is 53, she's been the Principal Accounting Officer & Corp. Controller of Lipocine Inc since . There are 7 older and 5 younger executives at Lipocine Inc. The oldest executive at Lipocine Inc is Dr. Mahesh V. Patel Ph.D., 64, who is the Co-Founder, Interim Principal Financial Officer, Chairman, Pres & CEO.
What's Ms Fogarty's mailing address?
Krista's mailing address filed with the SEC is 675 ARAPEEN DRIVE, SUITE 202, , SALT LAKE CITY, UT, 84108.
Insiders trading at Lipocine Inc
Over the last 11 years, insiders at Lipocine Inc have traded over $9,045 worth of Lipocine Inc stock and bought 890,945 units worth $696,169 . The most active insiders traders include Mahesh V. Patel, John W. Higuchi, eMorgan R Brown. On average, Lipocine Inc executives and independent directors trade stock every 72 days with the average trade being worth of $148,846. The most recent stock trade was executed by Mahesh V. Patel on 25 May 2023, trading 8,706 units of LPCN stock currently worth $43,791.
What does Lipocine Inc do?
lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.
What does Lipocine Inc's logo look like?
Complete history of Ms Fogarty stock trades at Lipocine Inc
Lipocine Inc executives and stock owners
Lipocine Inc executives and other stock owners filed with the SEC include:
-
Mahesh Patel,
Chairman of the Board, President, Chief Executive Officer -
Dr. Mahesh V. Patel Ph.D.,
Co-Founder, Interim Principal Financial Officer, Chairman, Pres & CEO -
Dr. Mahesh V. Patel,
Co-Founder, Chairman, Pres & CEO -
Morgan R. Brown CPA, CPA, M.B.A., MBA,
Corp. Sec. -
Morgan R. Brown CPA, M.B.A., CPA, MBA,
Exec. VP, CFO, Principal Accounting Officer & Corp. Sec. -
Morgan Brown,
Chief Financial Officer, Executive Vice President -
Nachiappan Chidambaram Ph.D.,
VP of Product Devel. -
John Higuchi,
Non-Executive Director -
Richard Ono,
Director -
Jeffrey Fink,
Director -
Stephen Hill,
Lead Independent Director -
Krista Fogarty,
Principal Accounting Officer & Corp. Controller -
Dr. Anthony DelConte M.D., M. D.,
Chief Medical Director -
Logan Morse,
VP of Sales, Marketing & Operations -
Jyrki Mattila,
Chief Business Officer -
Gregory Brooks Bass,
EVP and Chief Commercial Offic -
Srinivasan Venkateshwaran,
CTO and VP RandD -
Gerald T Simmons,
VP Corp Business Development -
Robert K. Merrell,
VP Finance -
Jill M. Jene,
Director -
Spyros Papapetropoulos,
Director -
Krista Fogarty,
Principal Accounting Officer -
George Nomikos,
Chief Medical Officer